Davide Ret
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Davide Ret has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Eva Untersmayr
Institute of Pathophysiology and Allergy Research, Centre of Pathophysiology, Infectiology and Immunology Medical University of Vienna Vienna Austria
8 shared publications - Johanna Rohrhofer
Institute of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria
3 shared publications - Larissa Koidl
Institute of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology Medical University of Vienna Vienna Austria
3 shared publications Denise Heiden
Department of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria
2 shared publicationsJohanna Rohrhofer
Institute of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria
2 shared publications- Lena Lutz
Institute of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria
2 shared publications
Latest Publications
- Open Access
- 30 September 2025
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 12, 1597284
Species-specific N-glycan patterns in animal and human breast milk samples
The main components of milk are protein, fat and carbohydrates. Glycans are complex carbohydrate structures covalently bound to proteins and lipids or exist freely in solutions. The function of glycans in nature is to contribute to structure, energy metabolism and encoding relevant biological information. In this study we have analyzed the content of sialic acids. Moreover, we assigned and compared the N-glycan profile of the milk casein and whey fraction from humans, infant formula, cows, horses, goats, and sheep. Conservation of terminal sialic acids on the glycan structures was achieved by stabilization via methylamidation. Human breast milk exhibitsa unique glycan profile, characterized byhighly fucosylated N-glycans and is rich in N-acetylneuraminic acid (Neu5Ac), while N-glycolylneuraminic acid (Neu5Gc), a sialic acid not synthesized in humans, was not detected. In contrast, other mammalians are characterized by a species-specific N-glycan profile with low amounts of fucosylated glycans and different amounts of Neu5Gc. Sheep’s milk has the highest amount of Neu5Gc, followed by goat’s milk, horse’s milk, and cow’s milk. In infant formula, the concentration of total sialic acid is reduced in comparison to human breast milk and contains approximately 7% of the non-human sialic acid Neu5Gc. Regarding the analysis of N-glycan profiles comparing casein and whey fractions, no differences were observed for human breast milk, only marginal differences for cow, horse, goat and sheep and pronounced differences in infant formula. Our work confirms that human breast milk has a unique N-glycan signature with a distinct glycan composition when compared to all other mammalian milk samples. No traces of the non-human sialic acid Neu5Gc were detected, whereas it was found in varying amounts throughout the other milk samples.
- 30 September 2025
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 12, 1597284
Open AccessSpecies-specific N-glycan patterns in animal and human breast milk samples
The main components of milk are protein, fat and carbohydrates. Glycans are complex carbohydrate structures covalently bound to proteins and lipids or exist freely in solutions. The function of glycans in nature is to contribute to structure, energy metabolism and encoding relevant biological information. In this study we have analyzed the content of sialic acids. Moreover, we assigned and compared the N-glycan profile of the milk casein and whey fraction from humans, infant formula, cows, horses, goats, and sheep. Conservation of terminal sialic acids on the glycan structures was achieved by stabilization via methylamidation. Human breast milk exhibitsa unique glycan profile, characterized byhighly fucosylated N-glycans and is rich in N-acetylneuraminic acid (Neu5Ac), while N-glycolylneuraminic acid (Neu5Gc), a sialic acid not synthesized in humans, was not detected. In contrast, other mammalians are characterized by a species-specific N-glycan profile with low amounts of fucosylated glycans and different amounts of Neu5Gc. Sheep’s milk has the highest amount of Neu5Gc, followed by goat’s milk, horse’s milk, and cow’s milk. In infant formula, the concentration of total sialic acid is reduced in comparison to human breast milk and contains approximately 7% of the non-human sialic acid Neu5Gc. Regarding the analysis of N-glycan profiles comparing casein and whey fractions, no differences were observed for human breast milk, only marginal differences for cow, horse, goat and sheep and pronounced differences in infant formula. Our work confirms that human breast milk has a unique N-glycan signature with a distinct glycan composition when compared to all other mammalian milk samples. No traces of the non-human sialic acid Neu5Gc were detected, whereas it was found in varying amounts throughout the other milk samples.
- Open Access
- 3 January 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (1) , 275
Immunological Patient Stratification in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex disease characterized by profound fatigue, post-exertional malaise (PEM), and neurocognitive dysfunction. Immune dysregulation and gastrointestinal symptoms are commonly observed in ME/CFS patients. Despite affecting approximately 0.89% of the general population, the underlying pathophysiological mechanisms remain poorly understood. This study aimed to elucidate the relationship between immunological characteristics and intestinal barrier function in ME/CFS patients. ME/CFS patients were stratified into two groups based on their immune competence. After documentation of detailed medical records, serum and plasma samples were collected for the assessment of inflammatory immune mediators and biomarkers for intestinal barrier integrity by ELISA. We found reduced complement protein C4a levels in immunodeficient ME/CFS patients suggesting a subgroup-specific innate immune dysregulation. ME/CFS patients without immunodeficiencies exhibit a mucosal barrier leakage, as indicated by elevated levels of Lipopolysaccharide-binding protein (LBP). Stratifying ME/CFS patients based on immune competence enabled the distinction of two subgroups with different pathophysiological patterns. The study highlights the importance of emphasizing precise patient stratification in ME/CFS, particularly in the context of defining suitable treatment strategies. Given the substantial health and socioeconomic burden associated with ME/CFS, urgent attention and research efforts are needed to define causative treatment approaches.
- 3 January 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (1) , 275
Open AccessImmunological Patient Stratification in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex disease characterized by profound fatigue, post-exertional malaise (PEM), and neurocognitive dysfunction. Immune dysregulation and gastrointestinal symptoms are commonly observed in ME/CFS patients. Despite affecting approximately 0.89% of the general population, the underlying pathophysiological mechanisms remain poorly understood. This study aimed to elucidate the relationship between immunological characteristics and intestinal barrier function in ME/CFS patients. ME/CFS patients were stratified into two groups based on their immune competence. After documentation of detailed medical records, serum and plasma samples were collected for the assessment of inflammatory immune mediators and biomarkers for intestinal barrier integrity by ELISA. We found reduced complement protein C4a levels in immunodeficient ME/CFS patients suggesting a subgroup-specific innate immune dysregulation. ME/CFS patients without immunodeficiencies exhibit a mucosal barrier leakage, as indicated by elevated levels of Lipopolysaccharide-binding protein (LBP). Stratifying ME/CFS patients based on immune competence enabled the distinction of two subgroups with different pathophysiological patterns. The study highlights the importance of emphasizing precise patient stratification in ME/CFS, particularly in the context of defining suitable treatment strategies. Given the substantial health and socioeconomic burden associated with ME/CFS, urgent attention and research efforts are needed to define causative treatment approaches.
- Open Access
- 30 November 2023
- Published by MDPI AG in Preprints.org
Immunological Patient Stratification in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a complex disease characterized by profound fatigue, post-exertional malaise (PEM), and neurocognitive dysfunction. Immune dysregulation and gastrointestinal symptoms are commonly observed in ME/CFS patients. Despite affecting approximately 0.89% of the general population, the underlying pathophysiological mechanisms remain poorly understood. This study aimed to elucidate the relationship between immunological characteristics and intestinal barrier function in ME/CFS patients. ME/CFS patients were stratified into two groups based on their immune competence. After documentation of detailed medical records, serum and plasma samples were collected for assessment of inflammatory immune mediators and biomarkers for intestinal barrier integrity by ELISA. We found reduced complement protein C4a levels in immunodeficient ME/CFS patients suggesting a sub-group specific innate immune dysregulation. ME/CFS patients without immunodeficiencies exhibit a mucosal barrier leakage, as indicated by elevated levels of Lipopolysaccharide-binding protein (LBP). Stratifying ME/CFS patients based on immune competence enabled the distinction of two subgroups with different pathophysiological patterns. The study highlights the importance of emphasizing precise patient stratification in ME/CFS, particularly in the context of defining suitable treatment strategies. Given the substantial health and socioeconomic burden associated with ME/CFS, urgent attention and research efforts are needed to define causative treatment approaches.
- 30 November 2023
- Published by MDPI AG in Preprints.org
Open AccessImmunological Patient Stratification in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a complex disease characterized by profound fatigue, post-exertional malaise (PEM), and neurocognitive dysfunction. Immune dysregulation and gastrointestinal symptoms are commonly observed in ME/CFS patients. Despite affecting approximately 0.89% of the general population, the underlying pathophysiological mechanisms remain poorly understood. This study aimed to elucidate the relationship between immunological characteristics and intestinal barrier function in ME/CFS patients. ME/CFS patients were stratified into two groups based on their immune competence. After documentation of detailed medical records, serum and plasma samples were collected for assessment of inflammatory immune mediators and biomarkers for intestinal barrier integrity by ELISA. We found reduced complement protein C4a levels in immunodeficient ME/CFS patients suggesting a sub-group specific innate immune dysregulation. ME/CFS patients without immunodeficiencies exhibit a mucosal barrier leakage, as indicated by elevated levels of Lipopolysaccharide-binding protein (LBP). Stratifying ME/CFS patients based on immune competence enabled the distinction of two subgroups with different pathophysiological patterns. The study highlights the importance of emphasizing precise patient stratification in ME/CFS, particularly in the context of defining suitable treatment strategies. Given the substantial health and socioeconomic burden associated with ME/CFS, urgent attention and research efforts are needed to define causative treatment approaches.
- Open Access
Association between Epstein‐Barr‐Virus reactivation and development of Long‐COVID fatigue
- Open Access
Nitrated food proteins induce a regulatory immune response associated with allergy prevention after oral exposure in a Balb/c mouse food allergy model
Background: Food allergy is associated with a high personal health and economic burden. For immunomodulation toward tolerance, food compounds could be chemically modified, for example, by posttranslational protein nitration, which also occurs via diet‐derived nitrating agents in the gastrointestinal tract.Objective: We sought to analyze the effect of pretreatment with nitrated food proteins on the immune response in a mouse food allergy model and on human monocyte‐derived dendritic cells (moDCs) and PBMCs.Methods: The model allergen ovalbumin (OVA) was nitrated in different nitration degrees, and the secondary structures of proteins were determined by circular dichroism (CD). Allergy‐preventive treatment with OVA, nitrated OVA (nOVA), and maximally nitrated OVA (nOVAmax) were performed before mice were immunized with or without gastric acid‐suppression medication. Antibody levels, regulatory T‐cell (Treg) numbers, and cytokine levels were evaluated. Human moDCs or PBMCs were incubated with proteins and evaluated for expression of surface markers, cytokine production, and proliferation of Th2 as well as Tregs.Results: In contrast to OVA and nOVA, the conformation of nOVAmax was substantially changed. nOVAmax pretreated mice had decreased IgE as well as IgG1 and IgG2a levels and Treg numbers were significantly elevated, while cytokine levels remained at baseline level. nOVAmax induced a regulatory DC phenotype evidenced by a decrease of the activation marker CD86 and an increase in IL‐10 production and was associated with a higher proliferation of memory Tregs.Conclusion: Oral pretreatment with highly nitrated proteins induces a tolerogenic immune response in the food allergy model and in human immune cells.
Open AccessNitrated food proteins induce a regulatory immune response associated with allergy prevention after oral exposure in a Balb/c mouse food allergy model
Background: Food allergy is associated with a high personal health and economic burden. For immunomodulation toward tolerance, food compounds could be chemically modified, for example, by posttranslational protein nitration, which also occurs via diet‐derived nitrating agents in the gastrointestinal tract.Objective: We sought to analyze the effect of pretreatment with nitrated food proteins on the immune response in a mouse food allergy model and on human monocyte‐derived dendritic cells (moDCs) and PBMCs.Methods: The model allergen ovalbumin (OVA) was nitrated in different nitration degrees, and the secondary structures of proteins were determined by circular dichroism (CD). Allergy‐preventive treatment with OVA, nitrated OVA (nOVA), and maximally nitrated OVA (nOVAmax) were performed before mice were immunized with or without gastric acid‐suppression medication. Antibody levels, regulatory T‐cell (Treg) numbers, and cytokine levels were evaluated. Human moDCs or PBMCs were incubated with proteins and evaluated for expression of surface markers, cytokine production, and proliferation of Th2 as well as Tregs.Results: In contrast to OVA and nOVA, the conformation of nOVAmax was substantially changed. nOVAmax pretreated mice had decreased IgE as well as IgG1 and IgG2a levels and Treg numbers were significantly elevated, while cytokine levels remained at baseline level. nOVAmax induced a regulatory DC phenotype evidenced by a decrease of the activation marker CD86 and an increase in IL‐10 production and was associated with a higher proliferation of memory Tregs.Conclusion: Oral pretreatment with highly nitrated proteins induces a tolerogenic immune response in the food allergy model and in human immune cells.
- 1 January 2019
- Published by Elsevier in Carbohydrate Polymers
- Vol. 204, 124-130
Exact determination of the degree of substitution of high molar mass hyaluronan by controlling the conformation in solution
- 1 January 2019
- Published by Elsevier in Carbohydrate Polymers
- Vol. 204, 124-130
Exact determination of the degree of substitution of high molar mass hyaluronan by controlling the conformation in solution
- Open Access
Mouse Chow Composition Influences Immune Responses and Food Allergy Development in a Mouse Model
Our diet is known to substantially influence the immune response not only by support of mucosal barriers but also via direct impact on immune cells. Thus, it was of great interest to compare the immunological effect of two mouse chows with substantial differences regarding micro-, macronutrient, lipid and vitamin content on the food allergic response in our previously established mouse model. As the two mouse chows of interest, we used a soy containing feed with lower fatty acid (FA) amount (soy-containing feed) and compared it to a soy free mouse chow (soy-free feed) in an established protocol of oral immunizations with Ovalbumin (OVA) under gastric acid suppression. In the animals receiving soy-containing feed, OVA-specific IgE, IgG1, IgG2a antibody levels were significantly elevated and food allergy was evidenced by a drop of body temperature after oral immunizations. In contrast, mice on soy-free diet had significantly higher levels of IL-10 and were protected from food allergy development. In conclusion, soy-containing feed was auxiliary during sensitizations, while soy-free feed supported oral tolerance development and food allergy prevention.
Open AccessMouse Chow Composition Influences Immune Responses and Food Allergy Development in a Mouse Model
Our diet is known to substantially influence the immune response not only by support of mucosal barriers but also via direct impact on immune cells. Thus, it was of great interest to compare the immunological effect of two mouse chows with substantial differences regarding micro-, macronutrient, lipid and vitamin content on the food allergic response in our previously established mouse model. As the two mouse chows of interest, we used a soy containing feed with lower fatty acid (FA) amount (soy-containing feed) and compared it to a soy free mouse chow (soy-free feed) in an established protocol of oral immunizations with Ovalbumin (OVA) under gastric acid suppression. In the animals receiving soy-containing feed, OVA-specific IgE, IgG1, IgG2a antibody levels were significantly elevated and food allergy was evidenced by a drop of body temperature after oral immunizations. In contrast, mice on soy-free diet had significantly higher levels of IL-10 and were protected from food allergy development. In conclusion, soy-containing feed was auxiliary during sensitizations, while soy-free feed supported oral tolerance development and food allergy prevention.
- Open Access
- 1 August 2018
- Published by Elsevier in Molecular Immunology
- Vol. 100, 14-20
Stability of allergens
- 1 August 2018
- Published by Elsevier in Molecular Immunology
- Vol. 100, 14-20
Open AccessStability of allergens
- Open Access
- 1 July 2018
- Published by Elsevier in Clinical Immunology
- Vol. 192, 30-39
Characterization of Vibrio cholerae neuraminidase as an immunomodulator for novel formulation of oral allergy immunotherapy
- 1 July 2018
- Published by Elsevier in Clinical Immunology
- Vol. 192, 30-39
Open AccessCharacterization of Vibrio cholerae neuraminidase as an immunomodulator for novel formulation of oral allergy immunotherapy